Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT04284943 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Surgical TreAtment for Obesity Related Disease and Onco-Metabolic Surgery

Study acronym: STARDOM
StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Primary completion date: Nov 2023 to Dec 2027
    • Study completion date: Dec 2023 to Dec 2027
    • Collaborators revised (5)
    v6
  2. Collaborators revised (5)v5
  3. Primary completion date: Nov 2021 to Nov 2023
    • Study completion date: May 2022 to Dec 2023
    v4
  4. Trial status: Not Yet Recruiting to Recruitingv3 Show 6 more changesShow less
    • Primary endpoints: 2 to 1
    • Enrollment target: 135 to 120
    • Start date changed from estimate of Nov 1, 2020 to Dec 1, 2020
    • Eligibility criteria expanded, about 18 words
    • Secondary endpoints: 20 to 19
    • Site details revised
  5. Primary completion date: Feb 2021 to Nov 2021v2 Show 5 more changesShow less
    • Start date: Apr 1, 2020 to Nov 1, 2020
    • Trial status: Recruiting to Not Yet Recruiting
    • Study completion date: Feb 2021 to May 2022
    • Study description revised
    • Site details revised
  6. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This is a prospective, multi-center, randomized controlled trial to compare Billroth II reconstruction versus conventional Roux-en-Y reconstruction versus long limb Roux-en-Y reconstruction for glycemic control in patients with concurrent type 2 diabetes and gastric cancer.
Trial Details
NCT Number NCT04284943
Lead Sponsor Korea University Anam Hospital
Collaborators: Korea University Ansan Hospital, Korea University Guro Hospital, Chonnam National University Hospital, Kyung Hee University Hospital at Gangdong, Ajou University
Conditions
(from sponsor)		 Gastric Cancer, Diabetes Mellitus, Type 2
Related terms Diabetes Mellitus, Type 2, Stomach Neoplasms
Enrollment 120 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov